Hashimoto M - Search Results

1

Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.

Shults CW, Rockenstein E, Crews L, Adame A, Mante M, Larrea G, Hashimoto M, Song D, Iwatsubo T, Tsuboi K, Masliah E. Shults CW, et al. Among authors: hashimoto m. J Neurosci. 2005 Nov 16;25(46):10689-99. doi: 10.1523/JNEUROSCI.3527-05.2005. J Neurosci. 2005. PMID: 16291942 Free PMC article.

2

alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells.

Hashimoto M, Hsu LJ, Rockenstein E, Takenouchi T, Mallory M, Masliah E. Hashimoto M, et al. J Biol Chem. 2002 Mar 29;277(13):11465-72. doi: 10.1074/jbc.M111428200. Epub 2002 Jan 14. J Biol Chem. 2002. PMID: 11790792 Free article.

3

Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3beta pathway. Implications for neuroprotection.

Hashimoto M, Sagara Y, Langford D, Everall IP, Mallory M, Everson A, Digicaylioglu M, Masliah E. Hashimoto M, et al. J Biol Chem. 2002 Sep 6;277(36):32985-91. doi: 10.1074/jbc.M202803200. Epub 2002 Jul 2. J Biol Chem. 2002. PMID: 12095987 Free article.

4

Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters.

Rockenstein E, Mallory M, Hashimoto M, Song D, Shults CW, Lang I, Masliah E. Rockenstein E, et al. Among authors: hashimoto m. J Neurosci Res. 2002 Jun 1;68(5):568-78. doi: 10.1002/jnr.10231. J Neurosci Res. 2002. PMID: 12111846

5

Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides.

Windisch M, Hutter-Paier B, Rockenstein E, Hashimoto M, Mallory M, Masliah E. Windisch M, et al. Among authors: hashimoto m. J Mol Neurosci. 2002 Aug-Oct;19(1-2):63-9. doi: 10.1007/s12031-002-0012-8. J Mol Neurosci. 2002. PMID: 12212795

6

Characterization of the human alpha-synuclein gene: Genomic structure, transcription start site, promoter region and polymorphisms.

Xia Y, Saitoh T, Uéda K, Tanaka S, Chen X, Hashimoto M, Hsu L, Conrad C, Sundsmo M, Yoshimoto M, Thal L, Katzman R, Masliah E. Xia Y, et al. Among authors: hashimoto m. J Alzheimers Dis. 2001 Oct;3(5):485-494. doi: 10.3233/jad-2001-3508. J Alzheimers Dis. 2001. PMID: 12214035

7

Development of new treatments for Parkinson's disease in transgenic animal models: a role for beta-synuclein.

Masliah E, Hashimoto M. Masliah E, et al. Among authors: hashimoto m. Neurotoxicology. 2002 Oct;23(4-5):461-8. doi: 10.1016/s0161-813x(02)00029-3. Neurotoxicology. 2002. PMID: 12428718 Review.

8

Alpha-synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease.

Hashimoto M, Takenouchi T, Rockenstein E, Masliah E. Hashimoto M, et al. J Neurochem. 2003 Jun;85(6):1468-79. doi: 10.1046/j.1471-4159.2003.01791.x. J Neurochem. 2003. PMID: 12787066 Free article.

9

Transgenic models of alpha-synuclein pathology: past, present, and future.

Hashimoto M, Rockenstein E, Masliah E. Hashimoto M, et al. Ann N Y Acad Sci. 2003 Jun;991:171-88. Ann N Y Acad Sci. 2003. PMID: 12846986 Review.

10

Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.

Hashimoto M, Rockenstein E, Crews L, Masliah E. Hashimoto M, et al. Neuromolecular Med. 2003;4(1-2):21-36. doi: 10.1385/NMM:4:1-2:21. Neuromolecular Med. 2003. PMID: 14528050 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,713 results

Search Page

Filters